PLOD1 and polycystic ovary syndrome: In our study, letrozole-treated rats showed increased body weight and PCOS-like reproductive and metabolic phenotypes, including significant changes in serum T, E2, LH, FSH, and P, IR, widespread metabolic abnormalities, disrupted estrous cycles, and polycystic ovaries.